DMK Pharmaceuticals (DMK) Restructures Executive Team
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices jump after Trump threatens to hit Iran 'very hard'
- Oracle reports earnings today: Analysts say this metric could 'catalyze higher multiples'
- UBS sees generational semiconductor boom, highlights stock winners
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
- UBS sees generational semiconductor boom, highlights stock winners
DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
October 19, 2023 4:05 PM EDTSeth Cohen is appointed Chief Financial Officer, bringing over thirty years of financial industry experience to DMK, and seasoned corporate lawyer John Dorbin assumes role of General Counsel Corporate Secretary
Appointments strengthen leadership team and provide financial and corporate expertise as the organization focuses on improving DMKs existing commercial product portfolio and reducing opioid related deaths
SAN DIEGO, Oct. 19, 2023 (GLOBE NEWSWIRE) --... More
